Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00223 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von Sejal Jain und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of South Florida, USF Health Morsani College of Medicine, Tampa, FL. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Gene Amplification, Enhancer Elements, Genetic. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE In lung squamous cell carcinoma (LUSC), Black patients show significantly higher incidence and lower overall survival than White patients. Although socioeconomic factors likely contribute to this survival disparity, genomic factors have yet to be elucidated in LUSC. METHODS Using 416 LUSC tumor samples in the Cancer Genome Atlas (TCGA), we assessed genomic and transcriptomic profiles by ancestry. We replicated our analyses in pan-cancer data from TCGA, the American Association of Cancer Research (AACR) Genomics Evidence Neoplasia Information Exchange (GENIE), and Columbia University Medical Center. RESULTS We found increased MYC amplification, LUSC-specific MYC enhancer amplification, and chromosome arm 8q (chr8q) gain to be significantly associated with genetic AFR (African) ancestry in LUSC in TCGA. Furthermore, expression of MYC target genes was significantly enriched in AFR samples. Local ancestry analysis identified correlation of chr8q gain with AFR ancestry at the MYC locus in TCGA. We also found a significant correlation between chr8q and AFR ancestry in multiple cancer types and pan-cancer in TCGA. Similarly, in a pan-cancer subset of AACR GENIE data, we found a significant correlation between chr8q gain and race. CONCLUSION Together, our data suggest that ancestry may influence amplification of not only MYC but also its enhancer in LUSC. They also suggest a role for genetic ancestry in chr8q aneuploidy in cancer. These studies further define and expand patients who may benefit from future anti- MYC therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of South Florida, USF Health Morsani College of Medicine, Tampa, FL.
- Department of Pediatrics, University of Washington, Seattle, WA.
- Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Pathology and Cell Biology at the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
- Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University, New York, NY.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.
ORCID-Profile: Sejal Jain, Xuechun Bai, Samyukta Mallick, Alexandria G Yao, Diane Allen-Gipson, Brian S Henick, Fatemeh Momen-Heravi, Alison M Taylor
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
Zitieren
APA
Jain, S., Bai, X., Mallick, S., Kinghorn, B., May, B., Yao, A. G., Allen-Gipson, D., Zhang, X., Henick, B. S., Momen-Heravi, F., Carrot-Zhang, J., & Taylor, A. M. (2024). Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma. JCO Precision Oncology. https://doi.org/10.1200/po.24.00223
Vancouver
Jain S, Bai X, Mallick S, Kinghorn B, May B, Yao AG, et al. Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma. JCO Precision Oncology. 2024. doi:10.1200/po.24.00223
BibTeX
@article{Jain2024,
author = {Jain, Sejal and Bai, Xuechun and Mallick, Samyukta and Kinghorn, Branden and May, Benjamin and Yao, Alexandria G and Allen-Gipson, Diane and Zhang, Xiaoyang and Henick, Brian S and Momen-Heravi, Fatemeh and Carrot-Zhang, Jian and Taylor, Alison M},
title = {Amplification of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00223}
}
EUVIMED